
Immunotherapy methods emerged on the oncology market as adoptive cell transfers, specifically chimeric antigen receptor (CAR) T-cell therapies, with clear benefits in hematologic malignancy treatment.
Immunotherapy methods emerged on the oncology market as adoptive cell transfers, specifically chimeric antigen receptor (CAR) T-cell therapies, with clear benefits in hematologic malignancy treatment.
Published: June 12th 2025 | Updated: June 16th 2025
Published: June 10th 2025 | Updated: June 12th 2025
Published: June 2nd 2025 | Updated: June 11th 2025
Published: June 3rd 2025 | Updated: June 11th 2025
Published: May 30th 2025 | Updated: June 5th 2025
Published: April 18th 2025 | Updated: April 21st 2025